Danaher Corporation acquired GE Biopharma (Cytiva) for approximately $21.4 billion (cash), a transaction completed in March 2020, structured as all cash + equity financing.
GE Biopharma (Cytiva) operates in Life Sciences, is based in Marlborough, Massachusetts (USA), had revenue of about ~$3.2B (FY2019).
Advisory firms were not disclosed for this transaction.